Efficacy of fexuprazan compared with rebamipide in Korean patients with gastritis: A matching-adjusted indirect comparison

Table 2 Matching-adjusted indirect comparison of outcome measures at two weeks after treatment

	Fexuprazan 10 mg BID[3], before matching (n = 102)	Fexuprazan 10 mg BID[3], after matching (n = 44.51)	Rebamipide 100 mg TID[4] (n = 225)
Erosion improvement rate	65.7	64.5	43.6
Risk difference (95%CI)	22.1 (10.9, 33.4)	21.0 (9.6, 32.3)
P value	< 0.01	< 0.01
Erosion healing rate	57.8	53.2	35.6
Risk difference (95%CI)	22.3 (10.8, 33.7)	17.6 (6.1, 29.2)
P value	< 0.01	0.003

¹Effective sample size was computed as the square of the summed weights divided by the sum of the squared weights.

Data are expressed as percentages of patients, unless specified otherwise.